Navigation Links
Cordex Pharma Presents 'New Frontiers in Cardiovascular Medicines' on January 29
Date:1/23/2009

f="http://www.cordexpharma.com/index2_files/investor.htm" target="_new">http://www.cordexpharma.com/index2_files/investor.htm. Registration for the webcast begins at 11:30 a.m. EST on Thursday, January 29. Please check in at least 5 minutes before the scheduled start time at 12:00 p.m. EST to allow for a short registration process. The webcast will be archived for at least 14 days following the presentation.

"We are pleased to have Dr. Stamler present his group's cutting-edge cardiovascular research at Duke University and the nitric oxide/redox imbalance in heart failure as a novel target for drug development," said Dr. Kuo, chief executive officer of Cordex. "While there are several available therapies for heart failure, Cordex's investigational drugs, which are based on proprietary technology developed by Dr. Stamler, are designed to restore nitric oxide/redox balance in the failing heart and improve excitation-contraction coupling and cardiac pumping efficiency."

Dr. Stamler completed his undergraduate studies at Brandeis University, earned his M.D. from Mount Sinai School of Medicine in New York City and completed his medical residency and fellowship training in both cardiology and pulmonary medicine at Harvard Medical School and the Brigham and Women's Hospital. Dr. Stamler joined the faculty of Harvard Medical School as Assistant Professor of Medicine in October 1993. In December 1993, he joined the faculty of Duke University as an Associate Professor of Medicine, and in 1996, was promoted to full Professor.

Dr. Stamler's work has centered on elucidating the fundamental physiological regulatory roles of nitric oxide mediated by S-nitrosylation, a ubiquitous protein modification. The ramifications of his work extend to all major classes of proteins: ion channels, receptors, G proteins, transcription factors, membrane trafficking proteins and num
'/>"/>

SOURCE Cordex Pharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Axikin Pharmaceuticals Spins out of Actimis
2. Asbestos, Pharmaceutical Liability, Construction Defects, Nanotech: Covered by Targeted CLE Teleconferences
3. FDA Issues Complete Response Letter to SCOLR Pharmas Abbreviated New Drug Application for CDT(R) 12-Hour Pseudoephedrine
4. BioMed Realty Trust Extends Leases With Vertex Pharmaceuticals Through 2015
5. Cracking the Code: Exclusive Conference to Reveal Secrets of Chinese Pharmaceutical Industry
6. Poniard Pharmaceuticals Announces Positive Tumor Response and Neuropathy Data from Phase 2 Clinical Trial of Picoplatin in Metastatic Colorectal Cancer
7. Cumberland Pharmaceuticals Appoints Lee Product Director
8. Genesis Pharmaceuticals Appoints KPMG to Help Develop a SOX 404 Compliance Program
9. ERYtech Pharma Signs an Agreement With the Penn Jersey Region of American Red Cross
10. Keryx Biopharmaceuticals to Present at the J.P. Morgan 27th Annual Healthcare Conference
11. Alseres Pharmaceuticals, Inc. Announces $1 Million Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... 2014 Today BioSpace , the leading life sciences employment ... spotlighting the life sciences community in Illinois , ... , Michigan , Minnesota , ... Ohio and Wisconsin . BioMidwest ... all job postings on BioSpace originating in this region in 2013. The ...
(Date:7/31/2014)... the sound-processing part of the mouse brain in a ... trees in view. Their imaging technique allows zooming in ... and it enabled the team to watch brain cells ... results, which represent a step toward better understanding how ... the journal Neuron . , In the past, ...
(Date:7/31/2014)... Graphite Metallizing Corporation announces GRAPHALLOY® bearings ... are uniquely suited to prevent loss of lubrication that ... high temperatures . , Recently, a manufacturer of ... at Graphite Metallizing to overcome problems with movement of ... pans containing blocks of powder mixture are loaded onto ...
(Date:7/31/2014)... Senomyx , Inc. (NASDAQ: ... taste science technologies to discover, develop, and commercialize ... ingredient supply industries, today reported financial results for ... second quarter with $33.6 million in cash and ... past quarter Senomyx achieved another important milestone with ...
Breaking Biology Technology:Midwest Biotech Leaders Featured On BioSpace Map 2New mapping approach lets scientists zoom in and out as the brain processes sound 2Graphite Metallizing Announces Bearings for High Temperature Oven Applications 2Graphite Metallizing Announces Bearings for High Temperature Oven Applications 3SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 2SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 3SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 4SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 5SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 6SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 7SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 8SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 9SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 10SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 11SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 12SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 13SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 14SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 15SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 16
... pET vectors for bacterial expression has been the cost ... In order to tackle this problem, DNA2.0 has developed ... free of IP constraints. pJexpress vectors are specifically engineered ... shown to express better than comparable pET vectors. pJexpress ...
... US Oncology, Inc ., one of the nation,s largest cancer care ... Most Admired Companies list for 2009. The company ranks third ... third time US Oncology has been honored with F ... named to the list in 2004 and 2007 in ...
... a leading provider of centralized ECG and eClinical technology, ... and related industries, announced today that it will be ... #1253/1254 at the 21st Annual DIA Euromeeting, 23-25 March ... to three speaking sessions, which will discuss the impact ...
Cached Biology Technology:DNA2.0 Introduces Freedom of Expression With a New Family of Bacterial Expression Vect:ors 2DNA2.0 Introduces Freedom of Expression With a New Family of Bacterial Expression Vect:ors 3US Oncology Named to FORTUNE Magazine's Most Admired Companies List for Third Time 2US Oncology Named to FORTUNE Magazine's Most Admired Companies List for Third Time 3ERT to Showcase Its Clinical Trials Portfolio at DIA's 21st Euromeeting 2ERT to Showcase Its Clinical Trials Portfolio at DIA's 21st Euromeeting 3
(Date:7/31/2014)... Two new meta-analyses involving tree nuts (almonds, Brazil nuts, ... were recently published in the online publications, British ... PLOS ONE (ii). The BMJ Open ... metabolic syndrome (MetS) criteria and showed that tree nut ... fasting blood glucose. The PLOS ONE article ...
(Date:7/30/2014)... Queen in Lewis Carroll,s Through the Looking Glass, ... University of Singapore improved a 35-year-old ecology model ... to millions of years. , The new model, ... the "Red Queen Effect," an evolutionary hypothesis introduced ... suggests that organisms must constantly increase their fitness ...
(Date:7/30/2014)... climate change on the world,s animal and plant ... to a new paper by a research team ... and other organizations. The authors claim that most ... when it comes to climate change. , ... on the "direct" threats of changing temperatures and ...
Breaking Biology News(10 mins):New international tree nut council study looks at nuts, diabetes and metabolic syndrome 2Classic Lewis Carroll character inspires new ecological model 2Classic Lewis Carroll character inspires new ecological model 3Conservation scientists asking wrong questions on climate change impacts on wildlife 2
... Old muscle got a shot of youthful vigor in a ... Berkeley, setting the path for research on new treatments for ... Parkinson,s diseases. In a new study to be published ... Nature , researchers identified two key regulatory pathways that ...
... The University of Delaware has received $400,000 from the ... of an ocean observing system for the Mid-Atlantic region, ... Cod, Mass., and out to the continental shelf. Nearly ... Mid-Atlantic coast. The initiative is part of the ...
... Pep Canadell from CSIRO and the Global Carbon Project, ... billions of tons of carbon dioxide (CO2) absorbed annually ... climate change mitigation worth hundreds of billions of dollars. ... stocks, challenges in quantifying changes in the size of ...
Cached Biology News:Stem cell researchers give old muscle new pep 2Stem cell researchers give old muscle new pep 3Stem cell researchers give old muscle new pep 4UD nets NOAA funding for Mid-Atlantic ocean observing 2Tropical forest sustainability: A climate change boon 2
... Detection Platform combines robust chemistry with ... sensitive, specific, and cost-effective detection method ... Platform offers exceptional performance with specificity ... high signal/background ratio, and an expanded ...
Request Info...
... Gel Band Purification Kit, 100. For the purification, ... fragments (0.1-10 kb) from solution and from TAE ... from solution in as little as 5 min ... min.Prepacked glass fiber matrix columns provide consistent results ...
BD BaculoGold Max-XP Insect Cell Medium 1 Liter...
Biology Products: